Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
» For Antidepressants, Maybe Three Targets Will Be Better than Two
For Antidepressants, Maybe Three Targets Will Be Better than Two
For Antidepressants, Maybe Three Targets Will Be Better than Two
Submitted by
admin
on February 10, 2009 - 7:07am
Source:
WSJ Online
News Tags:
antidepressants
TRIs
Neurosearch
AstraZeneca
Bristol-Myers Squibb
Dov
Headline:
For Antidepressants, Maybe Three Targets Will Be Better than Two
Do Not Allow Advertisers to Use My Personal information
